Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US-Listed China Biotechs Tank As Xi Takes Third Term
Uncertainties And Risks Seen Rising
Oct 26 2022
•
By
Brian Yang
US-LISTED CHINESE BIOTECHS NOSEDIVE ON UNCERTAINTIES FROM NEW CHINA LEADERSHIP • Source: Shutterstock
More from China
More from Focus On Asia